Literature DB >> 32240816

Perioperative outcomes comparing laparoscopic with open repeat liver resection for post-hepatectomy recurrent liver cancer: A systematic review and meta-analysis.

Yuelong Liang1, Chengping Lin1, Bin Zhang1, Jiasheng Cao1, Mingyu Chen1, Jiliang Shen1, Xu Feng1, Guangyuan Xiao2, Long Pan1, Ke Chen1, Hendi Maher1, Xiujun Cai3.   

Abstract

BACKGROUND: Repeat laparoscopic hepatectomy (LRH) offers an option for recurrent tumors in liver remnants following an initial liver resection of recurrent hepatocellular carcinoma (HCC), colorectal liver metastasis (CRLM) and cholangiocellular carcinoma (CCC), showing advantages in some outcomes. The objective of the study was to evaluate the feasibility, safety, and potential benefits of LRH in comparison with repeat open hepatectomy (ORH) for recurrent liver cancer.
METHODS: A systematic review was performed in compliance with the PRISMA (Preferred Reporting Items for Systematic Review and Meta-Analysis) and AMSTAR (Assessing the methodological quality of systematic reviews) guidelines. We performed a systematic search of PubMed, Embase, Cochrane Library, and Web of Science to identify studies that compared LRH with ORH from inception to September 30, 2019. Outcomes of interest included operation time, intraoperative estimated blood loss, length of hospital stay, complication rate, transfusion and R0 resection rate. The protocol was registered with the PROSPERO register of systematic reviews.
RESULTS: 10 retrospective observational studies were suitable for this analysis, involving 767 patients with 334 undergoing LRH (43.5%) and 433 undergoing ORH (56.5%). Compared with ORH, LRH had less intraoperative blood loss (SMD = -1.03; 95% CI: 1.48~-0.59, P < 0.001), less overall postoperative complications (OR = 0.40; 95% CI: 0.16-0.99, P = 0.048), less major complications (OR = 0.31, 95% CI: 0.15-0.62, P = 0.001), shorter hospital stay (SMD = -0.98; 95% CI: 1.41~-0.54, P < 0.001) and higher R0 resection rate (OR = 2.30, 95% CI: 1.39-3.81, P = 0.001). It was comparable in operation time (WMD = -7.66; 95% CI: 52.50-37.19, P = 0.738), transfusion rate (OR = 0.33; 95% CI:0.11-1.05, P = 0.060), and mortality (OR = 0.76; 95% CI: 0.27-2.18, P = 0.615) between LRH and ORH.
CONCLUSION: Our results indicate that LRH is a safe and effective technique. Benefits, especially less intra-operative blood loss, less complications rate, shorter hospital stay and higher R0 resection, might be offered in the laparoscopic approach.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  Laparoscopic; Meta-analysis; Open; Recurrent; Repeat hepatectomy

Year:  2020        PMID: 32240816     DOI: 10.1016/j.ijsu.2020.03.052

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  6 in total

Review 1.  Intrahepatic recurrence of hepatocellular carcinoma after resection: an update.

Authors:  Maria Tampaki; George Vasileios Papatheodoridis; Evangelos Cholongitas
Journal:  Clin J Gastroenterol       Date:  2021-03-27

2.  Laparoscopic vs. Open Repeat Hepatectomy for Recurrent Liver Tumors: A Propensity Score-Matched Study and Meta-Analysis.

Authors:  Jia-Feng Chen; Xiu-Tao Fu; Zheng Gao; Ying-Hong Shi; Zheng Tang; Wei-Ren Liu; Xin Zhang; Qiang Gao; Guang-Yu Ding; Kang Song; Xiao-Ying Wang; Jian Zhou; Jia Fan; Zhen-Bin Ding
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

3.  Short- and long-term outcomes of surgery for colorectal and non-colorectal liver metastasis: a report from a single center in the Baltic country.

Authors:  Rokas Račkauskas; Augustinas Baušys; Vitalijus Sokolovas; Marius Paškonis; Kęstutis Strupas
Journal:  World J Surg Oncol       Date:  2020-07-14       Impact factor: 2.754

Review 4.  Laparoscopic liver resection: indications, limitations, and economic aspects.

Authors:  Moritz Schmelzle; Felix Krenzien; Wenzel Schöning; Johann Pratschke
Journal:  Langenbecks Arch Surg       Date:  2020-07-01       Impact factor: 3.445

5.  Upgraded nomograms for the prediction of complications and survival in patients with colorectal liver metastases treated with neoadjuvant chemotherapy followed by hepatic resection.

Authors:  Qichen Chen; Rui Mao; Jianjun Zhao; Xinyu Bi; Zhiyu Li; Zhen Huang; Yefan Zhang; Jianguo Zhou; Hong Zhao; Jianqiang Cai
Journal:  Ann Transl Med       Date:  2021-02

Review 6.  Liver-Directed Treatment Options Following Liver Tumor Recurrence: A Review of the Literature.

Authors:  Christopher T Aquina; Mariam F Eskander; Timothy M Pawlik
Journal:  Front Oncol       Date:  2022-01-31       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.